In this article, we will discuss the 10 Unstoppable Stocks to Buy According to Hedge Funds.
As per Morgan Stanley, investors can see gains in equities and high-quality fixed income for 2025, despite a slowdown in global economic growth. In the Midyear Investment Outlook, Morgan Stanley Research strategists believe that the US assets, namely equities, government bonds, and corporate credit, can outperform their non-U.S. counterparts.
S&P 500 Can Reach 6,500, Says Morgan Stanley
According to the Morgan Stanley Research strategists’ base-case scenario, the S&P 500 is expected to climb to 6,500 by the middle of next year, thanks to the improvement in earnings. The US stocks are not expected to revisit their April lows in the near future, with strategists believing that Treasuries will increase as the US Fed reduces rates early next year. This will push yields on 10-year down to 3.45% by the middle of 2026.
Serena Tang, Morgan Stanley’s Chief Global Cross-Asset Strategist, sees broader markets remaining choppy for the upcoming 2 quarters, with the US Fed reacting to tariff-induced inflation. However, there is expected to be significant monetary easing ahead. Also, further deregulation in the US can bolster the US assets.
Amidst such trends, we will now have a look at the 10 Unstoppable Stocks to Buy According to Hedge Funds.
A large computer terminal full of complex calculations tracking the company’s cash flow and investment management decisions.
Our Methodology
To list the 10 Unstoppable Stocks to Buy According to Hedge Funds, we sifted through several online rankings to get an extensive list of the stocks that have increased at least ~30% over the past 6 months (as of June 24). Next, we mentioned the hedge fund sentiments around each stock, as of Q1 2025. Finally, we selected the ones popular among hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Unstoppable Stocks to Buy According to Hedge Funds
10. Monopar Therapeutics Inc. (NASDAQ:MNPR)
% Gain over 6 Months: ~51.9%
Number of Hedge Fund Holders: 10
Monopar Therapeutics Inc. (NASDAQ:MNPR) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, Chardan analyst Keay Nakae began coverage of the company’s stock with a “Buy” rating and a price objective of $60, as reported by The Fly. The firm cited potential in its late-stage Wilson disease treatment as well as an early-stage radiopharmaceutical pipeline for the rating. In the research note, the analyst mentioned that the company’s co-founder and Chief Executive Officer has a long history with the development of ALXN1840.
On May 7, 2025, Monopar Therapeutics Inc. (NASDAQ:MNPR) presented long-term efficacy and safety data for ALXN1840 (tiomolybdate choline). The data supported ALXN1840 as a potential treatment for Wilson disease. Pooled results from 3 clinical trials (n=255) exhibited sustained clinical benefits over a median treatment duration of 2.63 years. Monopar Therapeutics Inc. (NASDAQ:MNPR), in collaboration with Excel Diagnostics and Nuclear Oncology Center (EDNOC), announced that the physician-sponsored Expanded Access Program (EAP) for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu has received authorization to proceed from the US FDA.
Hedge Fund Resource Center